(Q35643956)

9 August 2017

1 reference

title

Transcutaneous immunization and immunostimulant strategies (English)

1 reference

9 August 2017

0 references

Gregory M Glenn

1

1 reference

9 August 2017

Richard T Kenney

series ordinal

2

1 reference

9 August 2017

Scott A Hammond

series ordinal

3

1 reference

9 August 2017

Larry R Ellingsworth

series ordinal

4

1 reference

9 August 2017

1 November 2003

1 reference

Immunology and Allergy Clinics of North America

9 August 2017

1 reference

9 August 2017

23

1 reference

9 August 2017

4

1 reference

9 August 2017

787-813

1 reference

Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

The human hair follicle immune system: cellular composition and immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization of domestic animals: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Adjuvantation of epidermal powder immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Survey of human-use adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Bacterial toxins as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Addressing parents' concerns: do vaccines cause allergic or autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization: T cell responses and boosting of existing immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Intradermal granulocyte-macrophage colony-stimulating factor alters cutaneous antigen-presenting cells and differentially affects local versus distant immunization in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Changes in epidermal Langerhans cells, gamma delta T cells and CD4 T cells after intradermal infection with recombinant vaccinia virus expressing cytokine genes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Langerhans cells at the sites of vaccinia virus inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Protection against influenza virus challenge by topical application of influenza DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Identification of secretory immunoglobulin A in human sweat and sweat glands

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

Immunoglobulins coat microorganisms of skin surface: a comparative immunohistochemical and ultrastructural study of cutaneous and oral microbial symbionts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900094-8

7 January 2021

10.1016/S0889-8561(03)00094-8

Identifiers

DOI

1 reference

9 August 2017

1 reference